Intubation Devices for Difficult Airway
(DA-TCI Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if the new TCI Articulating Introducer performs as well as the standard GlideRite Rigid Stylet in assisting with difficult airway intubations. Intubation involves placing a tube in the throat to aid breathing, which can be challenging for patients with specific medical histories or physical traits. The trial seeks participants who require oral intubation and have a history of difficult intubation or conditions such as neck radiation or surgeries. Individuals with a short neck, severe overbite, or sleep apnea may be suitable for this study. As an unphased trial, this study offers the chance to contribute to important research that could enhance intubation techniques for patients with challenging airways.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the TCI Articulating Device is safe for difficult airway intubation?
Research shows that both the GlideRite Rigid Stylet and the TCI Articulating Introducer Device assist with difficult intubations, which occur when inserting a tube into the airway is challenging.
For the GlideRite Rigid Stylet, studies have shown it can increase the success rate of first-attempt intubations. In one study, no failed intubations were reported when it was used, suggesting it is safe and effective.
The TCI Articulating Introducer Device is also promising. Its flexible tip adjusts to the shape of a person's airway. Research suggests it performs well in challenging cases, making intubation easier and safer. It has been shown to be faster and easier to use during difficult intubations compared to some other tools.
Both devices have been tested in medical settings with positive results. No major safety issues have been reported, making them well-tolerated options for patients needing difficult airway intubation.12345Why are researchers excited about this trial?
Researchers are excited about these new intubation devices because they offer innovative solutions for managing difficult airways. The GlideRite Rigid Stylet is designed to provide better maneuverability and control when guiding the tube into the trachea, which can be crucial in challenging situations. The TCI Articulating Introducer Device offers an articulating tip that allows for more precise navigation through tricky airway passages, potentially improving the success rate of intubations. Unlike traditional intubation methods that rely on static guides, these devices are engineered to enhance flexibility and precision, making them promising options for improving patient outcomes during airway management.
What evidence suggests that these intubation devices are effective for difficult airway management?
This trial will compare the effectiveness of two intubation devices for difficult airway management. Research has shown that the GlideRite Rigid Stylet, used by participants in one arm of this trial, aids in breathing tube placement when paired with a video laryngoscope. Studies found it successful in 224 out of 244 attempts. Another study showed that all breathing tubes were placed successfully within three attempts using this tool.
In another arm of this trial, participants will use the TCI Articulating Introducer Device, which is emerging as a promising option for difficult airway situations. It has been found to be faster, easier, and safer than fiber optic bronchoscopy (FOB). In emergency situations where other methods failed, the TCI proved very effective. Both devices have strong evidence supporting their effectiveness in managing challenging airways.13467Are You a Good Fit for This Trial?
This trial is for adults with a difficult airway, indicated by factors like limited mouth opening, high STOP BANG score (risk of sleep apnea), small thyromental distance, large neck circumference, or history of radiation to the neck. It's also for those who've had head/neck surgery or have certain anatomical challenges. People under 18, with tracheal narrowing, untreated hiatal hernia, full stomach or uncontrolled reflux can't join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endotracheal intubation using either the GlideRite Rigid Stylet or the TCI Articulating Introducer with a video laryngoscope
Follow-up
Participants are monitored for immediate outcomes such as successful intubation, ease of intubation, and any complications like blood in the airway
What Are the Treatments Tested in This Trial?
Interventions
- GlideRite Rigid Stylet
- TCI Articulating Introducer Device
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Louisville
Lead Sponsor
University of Utah
Collaborator